Clinical Trial Update: Study Evaluating Metabolic Syndrome in Subjects Undergoing Gastric Bypass Bariatric Syndrome

View source ↗

Summary

The study evaluating metabolic syndrome in morbid obesity patients undergoing gastric bypass has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Morbid Obesity

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Morbid Obesity, Metabolic Disease | Status: TERMINATED